Paula D. Bos will receive the Distinguished Scientist Award at the 2024 AACI/CCAF Annual Meeting

Rob Winn shared a post by AACI (Association of American Cancer Institutes) on LinkedIn:

“Congratulations to Massey’s Cancer Biology Research Program co-leader, Dr. Paula D. Bos, for this well-deserved recognition. Speaking on behalf of the Massey community, we are so proud!”

Quoting AACI:

“We are thrilled to announce that Dr. Paula D. Bos will receive the Distinguished Scientist Award at the 2024 AACI/CCAF Annual Meeting!

Dr. Bos, an associate professor of pathology at VCU Massey Comprehensive Cancer Center, is recognized for her groundbreaking research on tumor-promoting mechanisms by regulatory Treg cells. Her innovative work could lead to new adoptive transfer therapeutics for breast cancer.

Congratulations, Dr. Bos! Read more from our September Update here.”

Source: Rob Winn/LinkedIn and AACI (Association of American CQuotinancer Institutes)/LinkedIn

Robert A. Winn, M.D., is the Director and Lipman Chair in Oncology at VCU Massey Comprehensive Cancer Center and a professor at VCU School of Medicine. Winn oversees nearly 150 scientists and clinical investigators and is nationally recognized for his community engagement efforts. He manages a research lab focusing on lung cancer and health disparities, supported by NIH and Veterans Affairs Merit awards. Previously, he directed the University of Illinois Cancer Center and held various leadership roles at the University of Colorado Health Sciences Center.